Tema Cardiovascular and Metabolic ETF (HRTS)

$32.22 +0.30 (0.94%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 5,275
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Latest News on HRTS

How to capitalize on the weight loss revolution with Tema Obesity & Cardiometabolic ETF (HRTS)

Jul 27, 2024, 10:23 AM EDT - 9 months ago

How to capitalize on the weight loss revolution with Tema Obesity & Cardiometabolic ETF (HRTS)

HRTS: Generating Alpha In Obesity Treatment

Jul 25, 2024, 7:00 AM EDT - 9 months ago

HRTS: Generating Alpha In Obesity Treatment

HRTS: Exposure To GLP-1 Drug Developers Means Plenty Of Upside

Jul 19, 2024, 10:59 AM EDT - 9 months ago

HRTS: Exposure To GLP-1 Drug Developers Means Plenty Of Upside

Looking at Next Gen of Weight Loss: Tema ETFs CEO

Jun 17, 2024, 2:46 PM EDT - 10 months ago

Looking at Next Gen of Weight Loss: Tema ETFs CEO

What's Next for Weight Loss Stocks?

Apr 15, 2024, 1:12 PM EDT - 1 year ago

What's Next for Weight Loss Stocks?

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

Apr 10, 2024, 9:27 AM EDT - 1 year ago

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

AMGN ASND CYTK DXCM EW IBB IHE

Sign of top or next pop? Rush of new offerings spring up around Mag 7, weight loss

Mar 18, 2024, 6:24 PM EDT - 1 year ago

Sign of top or next pop? Rush of new offerings spring up around Mag 7, weight loss

MAGQ MAGS MAGX RSP TCAF

Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund

Nov 21, 2023, 1:15 PM EST - 1 year ago

Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund